Hypertension and nephrology

SEPTEMBER 13, 2021

[The treatment of patients with hypertension and HFpEF. The role of MRA (mineralocorticoid receptor antagonist), ARNI (angiotensin receptor blocker – neprilysin inhibitor), and the SGLT-2 inhibitors ( sodium-glucose-cotransporter-2 inhibitors)]

MASSZI Gabriella

[The prevalence of the symptomatic form of heart failure with preserved ejection fraction (HFpEF) often causes therapeutic problem for physicians. Hypertension is one of the most frequent concomitant illness among many comorbidities. Therefore its treatment, care and monitoring needs special attention, as well. Newer therapeutic options will be reviewed in the light of the results of the studies concerning treatment of HFpEF and high blood pressure.]

Hypertension and nephrology

SEPTEMBER 13, 2021

[Hypertension-infertility. Can be any connection between them?]


[Summary – Considering the pathomechanism, the risk factors, as well as the environmental and toxic effects, some associated illnesses, unhealthy life-style habits in the background of hypertension and infertility, significant overlapping can be found. The question arises; does play any role the hypertension in the development of infertility? In this article the author review the connection between the hypertension and infertility. ]

Journal of Nursing Theory and Practice

SEPTEMBER 30, 2020

[The Role of Movement Therapy in Balance Training and Fall Prevention of Patients with Osteo­porosis: A Systematic Review]

MISZORY Erika Viktória, JÁROMI Melinda, PAKAI Annamária

[Introduction: The frequent occuring of traumatic events resulting from falls among the patients with osteoporosis and their negative consequencies to the life quality make the application of efficient movement therapy interventions for preventing falls. The aim of the study: The authors’ purpose is to revise the effectiveness of movement therapy interventions regarding osteoporosis, mainly in the field of balance training and fall prevention. We carried out a detailed systematic literature... tovább »

Clinical Neuroscience

JULY 30, 2021

Management of bone metabolism in epilepsy

UÇAN TOKUÇ Ezgi Firdevs , FATMA Genç, ABIDIN Erdal, YASEMIN Biçer Gömceli

Many systemic problems arise due to the side effects of antiepileptic drugs (AEDs) used in epilepsy patients. Among these adverse effects are low bone mineral density and increased fracture risk due to long-term AED use. Although various studies have supported this association with increased risk in recent years, the length of this process has not been precisely defined and there is no clear consensus on bone density scanning, intervals of screening, and the subject of calcium and vitamin D... tovább »

Lege Artis Medicinae

JULY 13, 2021

[Potential benefits of using GLP1-receptor agonists during COVID-19 epidemic]

KIS János Tibor, SCHANDL László, GRÓSZ Andrea

[The risk of SARS-CoV-2 infection is higher among diabetic patients. The severity of progressing infection also increases in diabetes mellitus. Obesity associated with diabetes and cardiovascular disease are worsening the prognosis. Glucagon-like peptide-1 receptor agonists (GLP1-RA) administered in type 2 diabetes are lowering significantly the blood sugar level without increasing the risk of hypoglycaemia, support patients to lose weight, and reduce the likelihood of developing and worsening... tovább »